124 related articles for article (PubMed ID: 33492449)
1. Increased [
Shimizu Y; Nakai Y; Watanabe H; Iikuni S; Ono M; Saji H; Kuge Y; Saga T; Nakamoto Y
EJNMMI Res; 2021 Jan; 11(1):9. PubMed ID: 33492449
[TBL] [Abstract][Full Text] [Related]
2. FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
Masaki Y; Shimizu Y; Yoshioka T; Nishijima KI; Zhao S; Higashino K; Numata Y; Tamaki N; Kuge Y
Ann Nucl Med; 2017 Oct; 31(8):596-604. PubMed ID: 28695498
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of hypoxia imaging probe "
Shimizu Y; Motomura A; Takakura H; Tamaki N; Kuge Y; Ogawa M
Ann Nucl Med; 2019 May; 33(5):362-367. PubMed ID: 30694443
[TBL] [Abstract][Full Text] [Related]
4. [Accumulation Mechanism of 2-Nitroimidazole-based Hypoxia Imaging Probes Revealed by Imaging Mass Spectrometry].
Shimizu Y
Yakugaku Zasshi; 2018; 138(11):1345-1352. PubMed ID: 30381642
[TBL] [Abstract][Full Text] [Related]
5. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
6. Elimination of tumor hypoxia by eribulin demonstrated by
Zhao S; Yu W; Ukon N; Tan C; Nishijima KI; Shimizu Y; Higashikawa K; Shiga T; Yamashita H; Tamaki N; Kuge Y
EJNMMI Res; 2019 Jun; 9(1):51. PubMed ID: 31161539
[TBL] [Abstract][Full Text] [Related]
7. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
[TBL] [Abstract][Full Text] [Related]
8. A Novel PET Probe "[
Shimizu Y; Zhao S; Yasui H; Nishijima KI; Matsumoto H; Shiga T; Tamaki N; Ogawa M; Kuge Y
Mol Imaging Biol; 2019 Feb; 21(1):122-129. PubMed ID: 29845425
[TBL] [Abstract][Full Text] [Related]
9. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842
[TBL] [Abstract][Full Text] [Related]
10. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
11.
Yu W; Qiao F; Su X; Zhang D; Wang H; Jiang J; Xu H
Biomed Pharmacother; 2019 Nov; 119():109454. PubMed ID: 31526971
[TBL] [Abstract][Full Text] [Related]
12.
Grkovski M; Emmas SA; Carlin SD
J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia:
Watabe T; Kanai Y; Ikeda H; Horitsugi G; Matsunaga K; Kato H; Isohashi K; Abe K; Shimosegawa E; Hatazawa J
EJNMMI Res; 2017 Dec; 7(1):16. PubMed ID: 28210996
[TBL] [Abstract][Full Text] [Related]
15. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
[TBL] [Abstract][Full Text] [Related]
16. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668
[TBL] [Abstract][Full Text] [Related]
17. Dual-Tracer Assessment of Dynamic Changes in Reoxygenation and Proliferation Decrease During Fractionated Radiotherapy in Murine Tumors.
Yu W; Su X; Zhang D; Qiao F; Wang H; Jiang J; Xu H
Front Oncol; 2020; 10():1046. PubMed ID: 32766135
[No Abstract] [Full Text] [Related]
18. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
[TBL] [Abstract][Full Text] [Related]
19. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
Sorger D; Patt M; Kumar P; Wiebe LI; Barthel H; Seese A; Dannenberg C; Tannapfel A; Kluge R; Sabri O
Nucl Med Biol; 2003 Apr; 30(3):317-26. PubMed ID: 12745023
[TBL] [Abstract][Full Text] [Related]
20. Automated synthesis and PET evaluation of both enantiomers of [¹⁸F]FMISO.
Revunov E; Jørgensen JT; Jensen AI; Hansen AE; Severin GW; Kjær A; Zhuravlev F
Nucl Med Biol; 2015 Apr; 42(4):413-9. PubMed ID: 25595134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
